Real-world comparative effectiveness of tofacitinib, tumour necrosis factor inhibitors, and interleukin 17 inhibitors among patients with axial spondylarthritis and psoriatic arthritis

15/11/2024
25/06/2026
EU PAS number:
EUPAS1000000226
Study
Finalised

ENCePP Code of conduct

No information provided.
Data sources

Data source(s), other

Komodo’s Healthcare Map database

Data sources (types)

Administrative healthcare records (e.g., claims)
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

Unknown
Procedures
No information provided.